These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
412 related articles for article (PubMed ID: 24675179)
1. Synthesis, cytotoxicity and molecular modelling studies of new phenylcinnamide derivatives as potent inhibitors of cholinesterases. Saeed A; Mahesar PA; Zaib S; Khan MS; Matin A; Shahid M; Iqbal J Eur J Med Chem; 2014 May; 78():43-53. PubMed ID: 24675179 [TBL] [Abstract][Full Text] [Related]
2. Active compounds from a diverse library of triazolothiadiazole and triazolothiadiazine scaffolds: synthesis, crystal structure determination, cytotoxicity, cholinesterase inhibitory activity, and binding mode analysis. Khan I; Ibrar A; Zaib S; Ahmad S; Furtmann N; Hameed S; Simpson J; Bajorath J; Iqbal J Bioorg Med Chem; 2014 Nov; 22(21):6163-73. PubMed ID: 25257911 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, crystal structure and biological evaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines. Khan I; Zaib S; Ibrar A; Rama NH; Simpson J; Iqbal J Eur J Med Chem; 2014 May; 78():167-77. PubMed ID: 24681981 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors. Gao CZ; Dong W; Cui ZW; Yuan Q; Hu XM; Wu QM; Han X; Xu Y; Min ZL J Enzyme Inhib Med Chem; 2019 Dec; 34(1):150-162. PubMed ID: 30427217 [TBL] [Abstract][Full Text] [Related]
5. Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors. Asadipour A; Alipour M; Jafari M; Khoobi M; Emami S; Nadri H; Sakhteman A; Moradi A; Sheibani V; Homayouni Moghadam F; Shafiee A; Foroumadi A Eur J Med Chem; 2013; 70():623-30. PubMed ID: 24211638 [TBL] [Abstract][Full Text] [Related]
7. Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease. Tasso B; Catto M; Nicolotti O; Novelli F; Tonelli M; Giangreco I; Pisani L; Sparatore A; Boido V; Carotti A; Sparatore F Eur J Med Chem; 2011 Jun; 46(6):2170-84. PubMed ID: 21459491 [TBL] [Abstract][Full Text] [Related]
9. 7-MEOTA-donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies. Korabecny J; Dolezal R; Cabelova P; Horova A; Hruba E; Ricny J; Sedlacek L; Nepovimova E; Spilovska K; Andrs M; Musilek K; Opletalova V; Sepsova V; Ripova D; Kuca K Eur J Med Chem; 2014 Jul; 82():426-38. PubMed ID: 24929293 [TBL] [Abstract][Full Text] [Related]
10. Structural modifications of 4-aryl-4-oxo-2-aminylbutanamides and their acetyl- and butyrylcholinesterase inhibitory activity. Investigation of AChE-ligand interactions by docking calculations and molecular dynamics simulations. Vitorović-Todorović MD; Koukoulitsa C; Juranić IO; Mandić LM; Drakulić BJ Eur J Med Chem; 2014 Jun; 81():158-75. PubMed ID: 24836068 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors. Razavi SF; Khoobi M; Nadri H; Sakhteman A; Moradi A; Emami S; Foroumadi A; Shafiee A Eur J Med Chem; 2013 Jun; 64():252-9. PubMed ID: 23644208 [TBL] [Abstract][Full Text] [Related]
12. Preparation, anticholinesterase activity and molecular docking of new lupane derivatives. Castro MJ; Richmond V; Romero C; Maier MS; Estévez-Braun A; Ravelo AG; Faraoni MB; Murray AP Bioorg Med Chem; 2014 Jul; 22(13):3341-50. PubMed ID: 24835788 [TBL] [Abstract][Full Text] [Related]
13. New pyridine derivatives as inhibitors of acetylcholinesterase and amyloid aggregation. Pandolfi F; De Vita D; Bortolami M; Coluccia A; Di Santo R; Costi R; Andrisano V; Alabiso F; Bergamini C; Fato R; Bartolini M; Scipione L Eur J Med Chem; 2017 Dec; 141():197-210. PubMed ID: 29031067 [TBL] [Abstract][Full Text] [Related]
14. 4-Aryl-4-oxo-N-phenyl-2-aminylbutyramides as acetyl- and butyrylcholinesterase inhibitors. Preparation, anticholinesterase activity, docking study, and 3D structure-activity relationship based on molecular interaction fields. Vitorović-Todorović MD; Juranić IO; Mandić LM; Drakulić BJ Bioorg Med Chem; 2010 Feb; 18(3):1181-93. PubMed ID: 20061157 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3-alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors. Pejchal V; Štěpánková Š; Pejchalová M; Královec K; Havelek R; Růžičková Z; Ajani H; Lo R; Lepšík M Bioorg Med Chem; 2016 Apr; 24(7):1560-72. PubMed ID: 26947959 [TBL] [Abstract][Full Text] [Related]
16. Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones. Shah MS; Khan SU; Ejaz SA; Afridi S; Rizvi SUF; Najam-Ul-Haq M; Iqbal J Biochem Biophys Res Commun; 2017 Jan; 482(4):615-624. PubMed ID: 27865835 [TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase. Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949 [TBL] [Abstract][Full Text] [Related]
18. New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors. Karaman N; Sıcak Y; Taşkın-Tok T; Öztürk M; Karaküçük-İyidoğan A; Dikmen M; Koçyiğit-Kaymakçıoğlu B; Oruç-Emre EE Eur J Med Chem; 2016 Nov; 124():270-283. PubMed ID: 27592396 [TBL] [Abstract][Full Text] [Related]